MedTrace Logo

ED50 of Sufentanil for Intraoperative Analgesia

NCT06662656 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2024-10-29

No results posted yet for this study

Summary

1. Sufentanil as an strong analgesic is used widespreadly during laparoscopic cholecystectomy.
2. Lower dosages of sufentanil facilitated with dexmedetomidine can offer enough analgesia effect.
3. The investigator are planning use the most classical method for determining the ED50 or half effective concentration of sufentanil facilitated with dexmedetomidine using sequential method, which is also called" up and down method" and" ladder method".

Conditions

  • Laparoscopic Cholecystectomy
  • Analgesics，Opioid

Sponsors & Collaborators

  • China International Neuroscience Institution

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-01-30
Completion
2025-01-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06662656 on ClinicalTrials.gov